Search - tctmd.com

Displaying 281 - 300 of 493

Sort: Relevancy | Date

Presentation TCT 2014

Impella RP: Hemodynamic Support for the Failing Right Ventricle

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt, Ronan Margey

September 13, 2014

Presentation TCT 2014

How I Treated My Patient

Presenter: Srihari S. Naidu

September 13, 2014

Presentation TCT 2014

Put Your Ego Aside: Prophylactic Use Avoids Procedural Catastrophes and Improves Late Outcomes and Should be Used in This Case!

Presenter: David X. Zhao

September 13, 2014

Presentation TCT 2014

Prophylactic Hemodynamic Support is Expensive, Causes Complications, and Is Rarely Required in High-Risk PCI. Not in This Case!

Presenter: Antonio Colombo

September 13, 2014

Presentation TCT 2014

Case Presentation Setting the Stage: Should Prophylactic Hemodynamic Support Be Used?

Presenter: Srihari S. Naidu

September 13, 2014

Presentation TCT 2014

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Jonghanne Park

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) VA ECMO

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Aly El Banayosy

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) TandemHeart

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, David X. Zhao

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) Impella

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Cindy L. Grines

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) IABP

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Gert Richardt

September 13, 2014

Presentation TCT 2014

Overview and Comparative Analysis of Percutaneous Hemodynamic Support Devices

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Jeffrey W. Moses

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial

August 06, 2014

News Daily News

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Todd Neale

July 30, 2014

News Industry News

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

July 29, 2014

News Daily News

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Yael L. Maxwell

July 24, 2014

Advertisement

Impella RP: Hemodynamic Support for the Failing Right Ventricle

How I Treated My Patient

Put Your Ego Aside: Prophylactic Use Avoids Procedural Catastrophes and Improves Late Outcomes and Should be Used in This Case!

Prophylactic Hemodynamic Support is Expensive, Causes Complications, and Is Rarely Required in High-Risk PCI. Not in This Case!

Case Presentation Setting the Stage: Should Prophylactic Hemodynamic Support Be Used?

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Cardiogenic Shock: Dissecting the Data for (or Against) VA ECMO

Cardiogenic Shock: Dissecting the Data for (or Against) TandemHeart

Cardiogenic Shock: Dissecting the Data for (or Against) Impella

Cardiogenic Shock: Dissecting the Data for (or Against) IABP

Overview and Comparative Analysis of Percutaneous Hemodynamic Support Devices

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Another Strike Against Thrombectomy in 1-Year TASTE Results

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content